ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Adverum Biotechnologies, Inc.
The Director, HEOR leads the development and execution of evidence generation strategies across multiple marketed and pipeline assets, collaborating with cross‑functional teams to shape brand, asset, and enterprise decisions. This contract role is responsible for end‑to‑end HEOR program delivery, stakeholder alignment, and strategic impact communication with senior leadership and external audiences.
Headquarters
Redwood City, California, United States
Company Size
51-200 employees
Founded
2012
Adverum Biotechnologies is a clinical‑stage biotechnology company focused on developing ocular gene therapies to treat debilitating retinal diseases. The company aims to establish ocular gene therapy as a new standard of care by advancing in vivo gene‑delivery approaches (using viral vectors) to preserve or restore vision. Adverum advances multiple preclinical and clinical programs with an emphasis on translational science, regulatory engagement, and patient impact. Their tagline: "Redefining sight for life."
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Adverum Biotechnologies, Inc..
9% below the average for this role
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders
Oct 27, 2025
